ARCHIVES OF LEPROSY MAILING LIST
Archives of recent messages from Leprosy Mailing List (LML) managed by Dr Salvatore Noto.

Over the past few years, LML moderated by Dr Noto has become one of the most important online resource for promoting discussions about leprosy.

Contact LML Objectives of LML LML Archives

Leprosy Mailing List – August 29th, 2010

 

Ref.:   Clofazimine in ENL reaction

From: Ailton Santos Romero, Caruaru, Pernambuco , Brazil


 

 

Dear Dr. Noto

Drugs currently used in the treatment of reactions in leprosy are: non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and thalidomide. Thalidomide is the treatment of choice in erythema nodosum leprosum (ENL) or type 2 reaction, except for women of child bearing age.

 

In our centre, prednisolone and thalidomide, in men only, are the drugs of choice in ENL.  In the past in patients with relapsing and chronic ENL reaction we have also used a regimen containing clofazimine.  We found it useful in cases of steroid dependent ENL.  The doses of clofazimine that we used were:

300mg, the first month
200mg the second month
100mg in the third month
50mg in treatment continued until remission of the clinical picture.

Unfortunately loose clofazimine is currently not available in our country.

 

I would like asking the experience of colleagues about the use of such a regimen, particularly about the time of regression of the reaction using clofazimine.  We had excellent results with clofazimine, do others confirm this?


Thank you very much in advance for your collaboration. 

My sincere compliments,

Dr. Ailton Santos Romero

Reference Regional Medical Center
Leprosy and AIDS -
Health Department City of Caruaru
Pernambuco State

Brazil

Address:

Health Center , Amelia Bridges
Avenida Guararapes, S / N - Centre
City of Caruaru   CEP 55000-000
Pernambuco State

Brazil

 

<< BACK TO LML ARCHIVE INDEX

Italian Association Amici di Raoul Follereau (AIFO)

Contact

General

Project Support

Alliances & Links

Resources & Training

AIFO, Via Borselli 4-6, 40135 Bologna, Italy
Tel: +390-51-4393.211 Fax: +390-51-434046 Email: info@aifo.it